Because adult lung tissue has limited regeneration capacity, lung transplantation is the primary therapy for severely damaged lungs. To explore whether lung tissue can be regenerated in vitro, we treated lungs from adult rats using a procedure that removes cellular components but leaves behind a scaffold of extracellular matrix that retains the hierarchical branching structures of airways and vasculature. We then used a bioreactor to culture pulmonary epithelium and vascular endothelium on the acellular lung matrix. The seeded epithelium displayed remarkable hierarchical organization within the matrix and the seeded endothelial cells efficiently repopulated the vascular compartment. In vitro, the mechanical characteristics of the engineered lungs were similar to those of native lung tissue, and when implanted into rats in vivo for short time intervals (45-120 min), the engineered lungs participated in gas exchange. Although representing only an initial step toward the ultimate goal of generating fully functional lungs in vitro, these results suggest that repopulation of lung matrix is a viable strategy for lung regeneration.
Lung diseases account for some 400,000 deaths annually in the United States (1) . Human lungs do not generally repair or regenerate beyond the microscopic, cellular level. Currently, the only way to replace lung tissue is to perform lung transplantation, an expensive procedure that achieves only 10-20% survival at 10 years, and one that is hampered by a severe shortage of donor organs (2) . Recently, techniques have been developed to quantitatively decellularize complex organs such as heart, liver and kidney (3) (4) (5) . Acellular matrices can provide attractive scaffolds for repopulation with lung-specific cells for lung engineering, as the extracellular matrix template should contain appropriate three-dimensional architecture and regional-specific cues for cellular adhesion. To be functional in vivo, an engineered lung should (i) contain lung-specific cells, (ii) display the branching geometry of the airways and contain a perfusing microvasculature, (iii) provide barrier function to separate blood from air, and (iv) have mechanical properties that allow ventilation at physiological pressures.
Here we describe our progress toward the construction of a functional tissue-engineered lung, using rat as a model system. Our approach is summarized in Fig. 1 . We first decellularized native lung tissue to remove all immunogenic cellular constituents (Fig 1, A and B) . We found that after careful decellularization, the tissue retained its alveolar micro-architecture, its ability to function as a barrier to particulates, and its tissue mechanics. Repopulation of the acellular lung matrix with mixed populations of neonatal lung epithelial cells resulted in regional-specific epithelial seeding in correct anatomic locations. To enhance the survival and differentiation of lung epithelium, we cultured the matrix in a bioreactor designed to mimic certain features of the fetal lung environment, including vascular perfusion and liquid ventilation (Fig. 1, C and D) (6) . Finally, we tested the functionality of the engineered lung tissue by implanting it for short time periods in a syngeneic rat model (Fig. 1E) .
Preparation of a decellularized lung scaffold. We harvested lung tissue from adult Fischer 344 rats and treated the lungs in the vascular and airway compartments with detergent solutions (Fig. 1) (movie S1). The decellularization solution contains CHAPS, a zwitterionic detergent, in a phosphate buffer at 1.0M salt concentration (7) . Vascular perfusion pressure was maintained below 20 mmHg, with total time of tissue exposure typically in the range of 2-3 hours. Analysis of the decellularized lung matrices by highresolution micro-computed tomography (micro-CT) revealed intact lung architecture, and an intact arterial tree and microvasculature (Fig. 2, A to C) . The cells and nuclear material were removed by the decellularization process, but the alveolar septal architecture remained undisturbed (Fig. 2, / www.sciencexpress.org / 24 June 2010 / Page 2 / 10.1126/science.1189345 E and F). Fluorometric DNA assay confirmed that approximately 99% of DNA was removed by the decellularization process (Fig. 2G) , and immunoblotting for major histocompatibility complex I and II (MHC-I and MHC-II) as well as actin confirmed that decellularized lung matrices were depleted of these cellular markers (Fig. 2D) . Scanning electron microscopy confirmed that alveolar cells, red blood cells, and cellular proteins present in native lung were absent in the decellularized scaffold (Fig. 2, H and I,  and fig. S3 ). Analysis of the matrix by transmission electron microscopy revealed that the ultrastructure of the alveolar septae and the delicate microvessels surrounding the alveoli remained intact (Fig. 2J and fig. S3 ). Immunofluorescence and histochemical staining indicated that collagen, elastin and laminin were preserved in decellularized matrices (figs. S4 and S5). Additionally, quantitative assays showed that extracellular matrix collagen was preserved, whereas elastin was partially depleted by the decellularization process (40% of elastin remains in acellular matrices), and sulfated glycosaminoglycans (GAGs) were >90% removed ( Fig. 2G  and fig. S4 ). Hence, the lung decellularization protocol produces an acellular matrix scaffold that retains the gross, microstructural, and ultrastructural properties of native lung, yet removal of antigenic cellular components is essentially complete.
Properties of the lung bioreactor. The lung bioreactor contains a main reservoir in which the decellularized lung is mounted, using cannulae that are inserted into the trachea and pulmonary artery ( fig. S1A ). Culture medium is perfused into the pulmonary artery at physiological pressures (fig. S1B) (7). To provide negative-pressure ventilation of the engineered lung, a syringe pump withdraws a defined volume of air from the main bioreactor to create a negative pressure (Fig. 1C and figs. S1C and S2). Lung inflation under negative pressure is accompanied by inhalation of liquid medium from a trachea reservoir via a "breathing loop." For exhalation, the syringe pump returns air to the main reservoir, causing lung exhalation of liquid medium into the trachea reservoir.
To repopulate the decellularized matrix, we injected cells into the vascular or airway compartments, or both, and maintained the matrix in culture for up to 8 days (Fig. 1C) . This produced an engineered lung tissue that could then be removed from the bioreactor for further analysis, or that could be orthotopically transplanted into a rat recipient (Fig. 1, D and E).
Repopulation of acellular matrix to produce an engineered lung. Seeding of the decellularized matrix with mixed populations of neonatal rat lung epithelial cells (fig. S7) into the airway compartment generally resulted in good adherence of the cells to alveolar structures, as well as to small-and medium-sized airways (Fig. 3A) . Microvascular lung endothelial cells, when injected into the pulmonary artery of acellular scaffolds, adhered throughout the scaffold vasculature (Fig. 3B) . Seeded pulmonary epithelial cells replicated rapidly and rarely displayed markers of apoptotic cell death (Fig. 3 , C and D), despite the difficulty in culturing such cells on standard tissue culture plastic in vitro (8) . This observation suggests that substrate cues on the acellular lung matrix are important for pulmonary epithelial cell attachment and replication.
In the biomimetic bioreactor, vascular perfusion greatly enhanced endothelial adhesion and survival on the lung matrix ( fig. S9, A and B) . Interestingly, negative pressure ventilation had multiple beneficial effects on cultured lung epithelium, including enhanced survival of epithelium in distal alveoli and clearance of epithelial secretions from the airway tree ( fig. S9, C to F) . Clearance of airway secretions by ventilation indicates that the developing epithelium is in communication with the airway tree, and is not growing randomly within the matrix. In addition, ventilation with air, as opposed to with culture medium, increased the numbers of type I alveolar epithelial cells, as well as the numbers of ciliated columnar epithelial cells ( fig. S9 , G to J). Engineered lungs also produce pro-surfactant proteins B and C (pro-SPB, pro-SPC), although we could not detect mature SPB (Fig.  3E ). Surfactant proteins are critical for reducing alveolar surface tension and enabling lung inflation at physiologically normal pressures.
We performed compliance testing on the engineered lungs under quasi-static conditions by injecting air into the lungs and monitoring resultant pressure changes. Figs. 3F-H show typical compliance curves for native lung, acellular matrix, and repopulated engineered lungs. The compliance values were, respectively, 0.35 ± 0.08 (n = 10), 0.09 ± 0.02 (n = 4), and 0.14 ± 0.06 (n = 5) mL/mmHg (mean ± SD, P < 0.001 for difference between native and both decellularized and engineered compliances). Compliance values were measured at initial filling of the lungs (arrowheads in Figs. 3, F to H), and thus lower compliances for decellularized matrix and engineered lung mean that these two tissues have higher "opening pressures," and less functional surfactant, than does native lung. Despite this difference, the overall stress-strain relationships and the ultimate tensile stresses were similar between the three groups ( Fig. 3I and fig. S6 ). Thus, no significant stiffening or weakening of the extracellular matrix occurs in the repopulated, engineered lungs as compared with native adult lungs.
To evaluate the distribution and phenotype of cells in the engineered lungs, we performed fluorescent immunohistochemical staining ( fig. S8 ). Endothelial cells seeded into the vasculature were extensively distributed and expressed CD-31 as did comparable cells in native rat lung ( fig. S8A ). TEM analysis revealed the presence of tight junctions within the engineered endothelium, consistent with the development of some barrier function (fig. S10) . With respect to the seeded lung epithelium, CCSP-positive cells, which in native lung are found in small airways, were found primarily in very small airway structures after 4 days, and in larger structures after 8 days in engineered lungs ( fig. S8B) . Pro-SPC, a marker of type II alveolar epithelium, is normally present at the vertices of alveoli in native lung. In the engineered lungs, pro-SPC expression was diffuse in alveoli and in small airways after 4 days of culture, but at 8 days it showed a more native expression pattern at the vertices of alveoli ( fig. S8C) . In contrast, aquaporin-5, a specific marker for type I epithelium, was found diffusely throughout native alveoli and in engineered lungs after 4 days, but was largely absent after 8 days (fig. S8D ). This observation is consistent with previous work on neonatal rat development, which showed that type I cells do not fully differentiate until the post-natal period, when air breathing commences (9) . Indeed, engineered lungs that were ventilated with air, as opposed to liquid culture medium, displayed more aquaporin-5 expression in alveoli after 8 days of culture ( fig. S9G-H ) and also contained sparse ciliated epithelial cells ( fig. S9, I and J). Additional cell types noted included mesenchymal cells and the airway epithelial progenitor basal cells ( fig. S8, E and F) . Hence, the engineered lungs contained many of the important cell types of native lung tissues. In addition, the spatial distribution of the various cell types was regional-specific and with extended culture periods in the bioreactor, the overall pattern of cellular distribution and differentiation became more similar to that in native lung tissue. To determine whether the decellularization and repopulation methodologies used in our studies of rat lungs were applicable to human tissues, we obtained human lung segments from a tissue bank and treated them with decellularization solutions for up to 6 hours (7). Histological staining showed that complete cellular removal was achieved, with preservation of alveolar architecture ( fig. S11, A and B) . We seeded the acellular matrices with A549 human epithelial carcinoma cells and endothelial cells derived from human cord-blood endothelial progenitor cells (7) . The A549 cells adhered well to alveolar surfaces and the endothelial cells adhered to the vasculature ( fig. S11, C and D) , supporting the notion that these approaches may also be applicable to human lung tissues.
Implantation of engineered lungs into rats. To determine whether engineered rodent lungs were implantable and functional for gas exchange, we performed orthotopic left lung transplantation in 4 animals (7). Acellular matrices were seeded with neonatal rat lung epithelium and lung microvascular endothelium, and cultured for approximately 1 week in the bioreactor. For lung implantation, the native lungs were exposed via left thoracotomy and the left lung excised. After anticoagulation with heparin, the left mainstem bronchus, left pulmonary vein, and left pulmonary artery of the engineered lung were anastomosed to the recipient, the lung was ventilated with 100% oxygen, and blood flow was re-established.
In all cases, the engineered lungs were easily suturable to the recipient and they were ventilated with no visible air leak from the parenchyma (Fig. 4A ) (movie S2). All engineered lungs became perfused with blood over a period of seconds to minutes, with blood visibly turning from dark to bright red as the hemoglobin became oxygenated. Implantation times for engineered lungs ranged from 45 minutes to 2 hours. After perfusion and ventilation, blood gas samples were drawn from the pulmonary artery, left and right pulmonary veins (veins were clamped and samples drawn from each lung individually), and from the unclamped pulmonary vein, to document the extent of gas exchange occurring in the native and engineered lungs ( Table 1) .
Chest x-ray confirmed that the engineered lung was inflated with air, but the level of inflation was less than that of the native right lung (Fig. 4B) . Histological evaluation of explanted engineered lungs revealed red blood cells in large blood vessels and septal microvessels, and some bleeding into airways, although this was modest (Fig. 4C) . Most importantly, blood gas analysis revealed that the tissue engineered lungs were effective in exchanging oxygen and carbon dioxide (Table 1) . Partial pressures of oxygen increased from 27±7 mmHg in the pulmonary artery, to 283±48 mmHg in the left pulmonary vein, indicating complete hemoglobin saturation and oxygenation. Hemoglobin saturation was 100% for both engineered left lung and native right lung venous samples. In addition, carbon dioxide removal was efficient, with CO 2 falling from 41±13 mmHg in the pulmonary artery to 11±5mmHg in the left, engineered pulmonary vein. Although the partial pressure of oxygen in the right pulmonary vein was higher than in the left (634±69 vs. 283±48 mmHg), this difference may not be of substantial physiological consequence, since hemoglobin saturation is complete above oxygen pressures of 100 mmHg (10).
Discussion. To date, cell therapy and tissue engineering have been applied less extensively to lung than to other tissues and organs (11) (12) (13) . Many efforts in lung regeneration have involved synthetic scaffolds or simple in vitro culture systems. Such systems can regenerate certain microscopic features of alveolar architecture but have not yet produced tissue than can participate in gas exchange (14) (15) . Notably, use of the decellularization paradigm for respiratory tissue was described in 2008, when Macchiarini and colleagues implanted a re-seeded tracheal matrix into a patient with severe bronchomalacia (16) .
In the current work, we have demonstrated the feasibility of producing an engineered lung that displays much of the microarchitecture of native lung and that can effect gas exchange for short periods of time when implanted into rats. While these results are encouraging, multiple issues remain to be addressed before long-term engineered lung function can be realized. For example, alveolar barrier function must be improved, so as to prevent any leakage of blood components into the airways. This can be accomplished by iterative improvement in the decellularization procedure to minimize alveolar septal damage (17) . Production of surfactant should be increased (18) , and differentiated columnar ciliated epithelium should be enhanced by more prolonged air breathing in culture (19) . In addition, the efficiency of vascular endothelial coverage must be very high throughout the engineered lung vasculature. This is to prevent exposure of collagen-containing basement membrane to the circulation, with consequent thrombosis, since some clotting was noted at explant. Finally, a decellularization strategy for lung regeneration will only become clinically useful when a suitable, autologous source of pulmonary epithelium can be identified, such as a resident lung stem cell or induced pluripotent stem cell (20) (21) (22) (23) (24) 
